Non-Invasive Glucose Monitoring Device Market Size (2024 - 2029)

Non-Invasive Glucose Monitoring Device Market Analysis

The Non-Invasive Glucose Monitoring Device Market size is estimated at USD 8.53 billion in 2024, and is expected to reach USD 13.21 billion by 2029, growing at a CAGR of greater than 9% during the forecast period (2024-2029).

Non-invasive glucose meters represent devices that assess blood glucose levels without the need for blood extraction. This confers a notable benefit when compared to conventional glucose meters, as they necessitate a fingerstick to procure a blood sample. Non-invasive glucose meters are presently undergoing development, with numerous promising technologies currently under investigation.

Diabetes was recognized as a risk factor for numerous severe infections, particularly for the rapid progression and unfavorable prognosis of COVID-19. Consequently, individuals with diabetes needed heightened attention. This presented a significant clinical hurdle in managing diabetes during the pandemic period.

To mitigate the risk of coronavirus transmission, remote monitoring of glucose levels is imperative to deliver tailored home care. As a result, the advancement of personalized, continuous glucose monitoring (CGM) has garnered increased interest in effectively managing diabetes and preventing the spread of the virus. Therefore, in these unparalleled times, telemedicine intervention supporting CGM emerges as an ideal solution for diabetes management. It enables remote clinical consultations for diabetes patients through glucose self-monitoring, aided by personalized CGM devices. This approach not only maintains the effectiveness of diabetes care but also minimizes exposure to the virus among patients and residents, thereby contributing to global efforts against COVID-19.

Non-invasive glucose meters offer several benefits over traditional glucose meters, including the elimination of pain or discomfort. With no need for fingersticks, users can enjoy a painless and comfortable experience. Additionally, non-invasive glucose meters can be used more frequently since they don't require a blood sample, providing enhanced convenience. By offering more frequent glucose readings, non-invasive glucose meters can help individuals with diabetes achieve better glycemic control.

Certain obstacles must be overcome before non-invasive glucose meters can be embraced on a large scale despite their potential advantages. These obstacles include the fact that non-invasive glucose meters are not as precise as conventional glucose meters and can be influenced by factors such as skin temperature and humidity. Additionally, non-invasive glucose meters are usually more costly than traditional glucose meters.

Despite the obstacles, there exists considerable optimism regarding the prospects of non-invasive glucose meters in the future. Scientists persist in their efforts to innovate and create more precise and dependable technologies. With the progression of these technologies, it is anticipated that non-invasive glucose meters will likely become increasingly accessible and cost-effective.

Non-Invasive Glucose Monitoring Device Industry Segmentation

Non-invasive blood glucose monitoring, as its name suggests, pertains to the identification of human blood glucose levels without inflicting harm on human tissues. 

The non-invasive glucose monitoring device market is segmented by type (wearable and handled), by end-user (hospitals, clinics, and home care/personal), and by geography (North America, Europe, Asia-Pacific, the Middle East, Africa, and Latin America).

The report offers the value (in USD) and volume (in Units) for the above segments.